Haruko Yamamoto
Director, Center for Advancing Clinical and Translational Sciences, National Cerebral and Cardiovascular Center
-
Katsuhiko Ichimaru
Review Director, Office of New Drug IV, Pharmaceuticals and Medical Devices Agency (PMDA)
-
Akiko Ikeda
Associate Director, Regulatory Development Dept., Janssen Pharmaceutical K.K.
-
Yoichi Ishikawa
Professor, Department of Pediatric Medication, Meiji Pharmaceutical University
-
Yasushi Jotatsu
Managing Director, Department of Innovative Drug Discovery and Development, Japan Agency for Medical Research and Development (AMED)
-
Toshitaka Kawaratani
Consulting and Navigation Unit, Partner, CMIC holidings Co., Ltd.
-
Shigehiro Miki
Representative Director, General Manager - Japan, PAREXEL International Inc.
-
Harumasa Nakamura
Director of Department of Clinical Research Support, , National Center of Neurology and Psychiatry
-
Junichi Nishino
Head, Regulatory Affairs Department, Otsuka Pharmaceutical Co., Ltd.
-
Satoshi Saeki
Head of Japan Operational Excellence, Medical Affairs, Japan, Astellas Pharma Inc.
-
Eri Sekine
Executive Vice President, CMIC Co., Ltd.
-
Masahiro Takahata
Division Director, Planning and Mnagement Office of International Programs, Pharmaceuticals and Medical Devices Agency (PMDA)
-
Hideo Tomiya
Executive Director, Pharmaceutical and Medical Device Regulatory Science Society of Japan (PMRJ)
-
Atsushi Tsukamoto
Corporate Officer, Head is Therapeutic Area Strategies , Daiichi Sankyo
-
Kaori Watanabe
CRC, Clinical Research Promotion Center, The University of Tokyo Hospital
-
Takayuki Yoshino
Department of Gaestrointestinal Oncology, National Cancer Center Hospital East